Cough in Children: Current Approaches to the Treatment
Journal Title: Здоров`я дитини - Year 2016, Vol 2, Issue 70
Abstract
Introduction. Cough is one of the most common symptoms in the practice of doctors of various specialties, including pediatricians. Cough treatment should be started with the identification of its cause and correct diagnosis. Most often, cough in children is due to the increased viscosity of bronchial secretions, i.e. violation of sputum transport in the bronchial tree, and insufficient activity of ciliated epithelium. The main objective of the treatment of productive cough is dilution of sputum, bronchial secretion and excretion, thus necessitating the administration of mucolytics. Currently, one of the most famous mucolytics is acetylcysteine, cysteine amino acid product, such as ACC®. However, today the question of ACC® (acetylcysteine) application in infants and young children is still debatable. This article presents a study whose objective was to evaluate the therapeutic efficacy and tolerability of ACC® (20 mg/ml solution) in the treatment of bronchopulmonary diseases in children aged 2 to 6 years. Materials and methods. The study involved 60 children with acute tracheitis, simple bronchitis, acute obstructive bronchitis, recurrent bronchitis in the acute phase, community-acquired pneumonia, asthma exacerbation, cystic fibrosis. Patients of the main groups (n = 40) received ACC® (20 mg/ml solution) at the age-specific dosage 3 times a day in combined treatment. Therapy of patients in the control group (n = 20) was conducted without ACC®. Results. During follow-up, patients who received ACC® had significant positive changes in the nature of cough, sputum viscosity and its amount as opposed to a comparison group of patients. Complete disappearance of cough was achieved on day 5–8 from the beginning of treatment, while in the control group patients, this time was longer. The evaluation of the effectiveness of the study drug showed that very good efficacy was achieved in 75 % of patients and good — in 20 %, and among patients who received other mucolytic agents — in 50 and 30 %, respectively. Discussion. The findings suggest that the use of ACC® (acetylcysteine) in the combination treatment of children with bronchopulmonary pathology enables to make dry cough wet and productive. Unlike other expectorants, ACC® (acetylcysteine) has a more pronounced and rapid mucolytic effect with good tolerability. Conclusions. Mucolytic agent ACC® can be recommended as a drug of choice in the treatment of acute tracheitis and bronchitis, pneumonia, cystic fibrosis from the first days of the disease in children aged 2 years and more both in the hospital and in an outpatient setting. Acetylcysteine should be administered with caution to the patients with bronchial asthma.
Authors and Affiliations
O. O. Rechkina
Keywords
Related Articles
- EP ID EP194233
- DOI -
- Views 95
- Downloads 0
Characteristics of the heart rhythm in children with gastroesophageal reflux disease
Background. Incidence of gastroesophageal reflux disease (GERD) increases in patients from different age groups throughout the world. Studying the extraesophageal manifestations, including cardiologic symptoms of GERD, i...
Predictors of Bronchopulmonary Dysplasia Formation
The authors studied and analyzed a group of prenatal, intra-, and neonatal factors leading to the development of bronchopulmonary dysplasia (BPD). Nnegative impact of BPD on the development of chronic bronchopulmonary pa...
Evaluating the quality of life in children with gastroesophagel reflux disease
Background. The purpose of the study was the assessment of the quality of life in adolescents with gastroesophageal reflux disease (GERD) during the treatment. Materials and methods. 49 children aged 13–17 years with gas...
Тhe сlinical and мorphological сharacteristics оf nephropathy first manifested with isolated hematuria
Background. Nephropathy associated with hematuria progress represent the greatest differential diagnostic difficulties because of the similarity of clinical manifestations, especially at the early stages of the disease,...
Atopic march in pediatrics: genotype-associated mechanisms Part 1. Genotype-associated mechanisms of the atopic march in children
The review deals with the data of studies over last 10 years of populations of different countries on association of atopic diseases being the components of the atopic march in children (atopic eczema, allergic rhinitis,...